Tyra Biosciences Inc’s recent filing unveils that its Director Kjellson Nina S unloaded Company’s shares for reported $74324.0 on Feb 05 ’25. In the deal valued at $13.76 per share,5,401 shares were sold. As a result of this transaction, Kjellson Nina S now holds 443,885 shares worth roughly $3.87 million.
Then, Canaan XI, LP bought 120,000 shares, generating $1,650,000 in total proceeds.
Before that, Canaan 2020 Plus Co-Investment bought 112,500 shares. Tyra Biosciences Inc shares valued at $1,546,875 were divested by the Director at a price of $13.75 per share.
UBS initiated its Tyra Biosciences Inc [TYRA] rating to a Buy in a research note published on January 07, 2025; the price target was $28. A number of analysts have revised their coverage, including BofA Securities’s analysts, who increased its forecast for the stock in mid October from “a Neutral” to “a Buy”. Piper Sandler began covering TYRA with “an Overweight” recommendation on August 15, 2024. BofA Securities revised its rating on December 15, 2023. It rated TYRA as “a Neutral” which previously was an “a Buy”.
Price Performance Review of TYRA
On Tuesday, Tyra Biosciences Inc [NASDAQ:TYRA] saw its stock fall -6.24% to $8.72. Over the last five days, the stock has lost -15.42%. Tyra Biosciences Inc shares have fallen nearly -37.27% since the year began. Nevertheless, the stocks have fallen -46.83% over the past one year. While a 52-week high of $29.60 was reached on 01/15/25, a 52-week low of $9.05 was recorded on 04/01/25. SMA at 50 days reached $12.24, while 200 days put it at $17.40.
Levels Of Support And Resistance For TYRA Stock
The 24-hour chart illustrates a support level at 8.45, which if violated will result in even more drops to 8.18. On the upside, there is a resistance level at 9.20. A further resistance level may holdings at 9.68. The Relative Strength Index (RSI) on the 14-day chart is 25.48, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.12, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 98.10%. Stochastics %K at 7.76% indicates the stock is a buying.
How much short interest is there in Tyra Biosciences Inc?
A steep rise in short interest was recorded in Tyra Biosciences Inc stocks on 2025-03-14, growing by 0.23 million shares to a total of 3.92 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 3.68 million shares. There was a rise of 5.95%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on June 30, 2023 when Wedbush began covering the stock and recommended ‘”an Outperform”‘ rating along with a $27 price target.
